Mondadori Store

Trova Mondadori Store

Benvenuto
Accedi o registrati

lista preferiti

Per utilizzare la funzione prodotti desiderati devi accedere o registrarti

Vai al carrello
 prodotti nel carrello

Totale  articoli

0,00 € IVA Inclusa

Sigma Receptors: Their Role in Disease and as Therapeutic Targets
Sigma Receptors: Their Role in Disease and as Therapeutic Targets

Sigma Receptors: Their Role in Disease and as Therapeutic Targets


pubblicato da Springer International Publishing

Prezzo online:
149,75
166,39
-10 %
166,39

Originally confused with opioid receptors and then orphan receptors with no biological function, Sigma Receptors are now recognized as relevant to many degenerative diseases with remarkable potential as therapeutic targets. In this text, new information about the structure of sigma 1 receptor, its binding sites are provided as well as its expression in many cell types. It's putative role in degenerative neuronal diseases including amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, pain, drug addiction and locomotor activity. Their roles in possible treatments for blinding retinal diseases emphasize the tremendous far-reaching potential for ligands for these receptors. Exciting breakthroughs in this dynamic field in the last decade are reported herein, which will guide future investigators in determining the full potential of this unique, yet abundantly expressed protein.

Dettagli down

Generi Scienza e Tecnica » Medicina » Biologia » Biologia molecolare » Biochimica » Chimica

Editore Springer International Publishing

Formato Ebook con Adobe DRM

Pubblicato 16/03/2017

Lingua Inglese

EAN-13 9783319501741

0 recensioni dei lettori  media voto 0  su  5

Scrivi una recensione per "Sigma Receptors: Their Role in Disease and as Therapeutic Targets"

Sigma Receptors: Their Role in Disease and as Therapeutic Targets
 

Accedi o Registrati  per aggiungere una recensione

usa questo box per dare una valutazione all'articolo: leggi le linee guida
torna su Torna in cima